Creating powerful collaborations that deliver impact in cell and gene therapies
CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies. CGT Catapult’s vision for the UK Industry is: globally-leading companies delivering transformative medicine to the world.
We are a team of experts covering all aspects of advanced therapies. Applying our unique capabilities and assets, we collaborate with academia, industry, and healthcare providers to develop new technology and drive innovation.
Our purpose is to help and support companies to develop and deliver transformative medicines to the world
We work to support the advancement of the ATMP sector, and have identified four interconnected conditions to be met for the ATMP sector to progress, aligning our activities to address these.
New therapeutics
Delivering a strong pipeline of novel ATMPs that not only demonstrate high clinical efficacy but also extend their impact to a broader range of diseases.
Lower cost of goods
Ensuring manufacturing costs for ATMPs are reduced, enabling increased patient access and scalability.
Manufacturing at scale
The sector needs a fully robust and scalable manufacturing infrastructure to support the growing and dynamic demands of this rapidly expanding field.
High uptake by healthcare systems
Ensuring healthcare systems can increase uptake of ATMPs, with evolving reimbursement models and adoption pathways supporting their integration into routine care.
Creating opportunities across the UK
Our outputs leverage research, transform barriers into industrial advantage and help to attract new investment for our collaborators.
We support people in acquiring new skills, organisations in establishing new capabilities, and policymakers in developing new perspectives.
Part of the Innovate UK Catapult Network
CGT Catapult is part of a network of world-leading technology and innovation centres, established by Innovate UK. The Innovate UK Catapult network foster collaborations between industry, government, research organisations, academia, and many others to transform great ideas into valuable products and services.
Working on a cell or gene therapy innovation challenge?
Contact us today to find out how we can support you.